Stage FocusSeed, Series A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
Pfizer Ventures was founded in 2004 as the strategic CVC arm of Pfizer, managing roughly $600M in AUM. Over 20 years, the firm has made 220 total investments, averaging 3 new deals annually, with 72 companies invested and 17 portfolio companies acquired.
The notable recent exit was Morphic Therapeutic, acquired by Eli Lilly for $3.2B in July 2024. The latest investment was Mission Therapeutics' S...
Notable Investments
M
Mission TherapeuticsM
Morphic TherapeuticSimilar Funds
Novartis Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Roche Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Sanofi Ventures
Paris, France
GeneralistBiotechMedTechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A